The drugmaker Merck announced it has opened a $1 billion vaccine manufacturing facility in north Durham, a ...

Merck says those efforts aim to expand domestic manufacturing as well as research and development capabilities. Additionally, the moves created new jobs. Merck also said it expects to invest ...

Both Merck & Co. and Halozyme are holding their ground in a freshly unveiled patent dispute surrounding the New Jersey pharma ...

Merck and scientists had only a "paucity" of evidence suggesting a causal connection between Gardasil and the alleged symptoms. He said that meant the Rahway, New Jersey-based drugmaker had no ...

A new patent dispute is brewing between Halozyme Therapeutics (NASDAQ:HALO), a biotech focused on drug delivery technology, ...

FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey ...

Merck (NYSE: MRK) has opened a new 225,000-square-foot vaccine manufacturing facility in Durham. The pharmaceutical company, headquartered in New Jersey, is also in the process of developing ...

Keytruda, also known as pembrolizumab, accounts for the bulk of the Rahway, New Jersey-based pharmaceutical giant's revenue. However, with its U.S. patent exclusivity ending in 2028, Merck (NYSE ...

Rahway, New Jersey-based Merck & Co., Inc. (MRK) functions as a healthcare company. Valued at $252.4 billion by market cap, the company delivers health solutions through its prescription ...